•
Sep 30, 2022

Tenet Healthcare Q3 2022 Earnings Report

Tenet Healthcare's Q3 2022 results were announced, featuring a $1 billion share repurchase program.

Key Takeaways

Tenet Healthcare reported a net income of $131 million, or $1.16 per diluted share, and an adjusted EPS of $1.44. The company's adjusted EBITDA was $841 million. A $1 billion share repurchase program was also announced.

Net income from continuing operations available to common shareholders was $131 million, or $1.16 per diluted share.

Adjusted diluted earnings per share from continuing operations was $1.44.

Consolidated Adjusted EBITDA was $841 million.

Board of Directors authorized a $1 billion share repurchase program.

Total Revenue
$4.8B
Previous year: $4.89B
-1.9%
EPS
$1.22
Previous year: $4.2
-71.0%
Admissions growth
-0.7%
Previous year: 2.6%
-126.9%
Gross Profit
$3.98B
Previous year: $4.07B
-2.0%
Cash and Equivalents
$1.21B
Previous year: $2.29B
-47.3%
Free Cash Flow
$150M
Previous year: $321M
-53.3%
Total Assets
$27.1B
Previous year: $25.9B
+4.5%

Tenet Healthcare

Tenet Healthcare

Tenet Healthcare Revenue by Segment

Forward Guidance

Tenet Healthcare provided its outlook for the full year 2022.

Revenue & Expenses

Visualization of income flow from segment revenue to net income